Comparison and Evaluation of Cardiac Biomarkers in Patients with Intermittent Claudication: Results from the CAVASIC Study | Zendy

Barbara Kollerits | Zendy; Gisela Sturm | Zendy; Claudia Lamina | Zendy; Angelika HammererLercher | Zendy; Barbara Rantner | Zendy; Marietta Stadler | Zendy; Tim Ziera | Zendy; Joachim Struck | Zendy; Peter Klein-Weigel | Zendy; Gustav Fraedrich | Zendy; Florian Kronenberg | Zendy

Open Access

Comparison and Evaluation of Cardiac Biomarkers in Patients with Intermittent Claudication: Results from the CAVASIC Study

Author(s) -

Barbara Kollerits,

Gisela Sturm,

Claudia Lamina,

Angelika HammererLercher,

Barbara Rantner,

Marietta Stadler,

Tim Ziera,

Joachim Struck,

Peter Klein-Weigel,

Gustav Fraedrich,

Florian Kronenberg

Publication year - 2013

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2012.193656

Subject(s) - medicine , claudication , natriuretic peptide , cardiology , odds ratio , intermittent claudication , cohort , diabetes mellitus , vascular disease , endocrinology , arterial disease , heart failure

Plasma concentrations of the peptides midregional proadrenomedullin (MR-proADM), midregional proatrial natriuretic peptide (MR-proANP), and C-terminal endothelin-1 precursor fragment (CT-proET-1) are increased in various cardiovascular conditions. However, there is limited information about the association and comparative performance of these peptides in peripheral arterial disease (PAD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research